Retour
Fourchette du Jour
115,00 €
115,00 €
Fourchette 52 Semaines
66,68 €
115,00 €
Volume
217
Moyenne 50J / 200J
104,50 €
/
85,30 €
Clôture Précédente
115,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 171,3 | 0,3 |
| P/B | 5,2 | 2,9 |
| ROE % | 3,1 | 3,7 |
| Net Margin % | 3,1 | 3,8 |
| Rev Growth 5Y % | 13,9 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
4,58 €
4,51 € – 4,64 €
|
520 M | 1 |
| FY2028 |
3,21 €
3,17 € – 3,26 €
|
450 M | 1 |
| FY2027 |
2,30 €
2,27 € – 2,33 €
|
390 M | 1 |
Points Clés
Revenue grew 13,92% annually over 5 years — strong growth
Earnings grew 136,65% over the past year
ROE of 3,06% is below average
Generating 9,34M in free cash flow
P/E of 171,25 — premium valuation
PEG of 0,75 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
13,92%
Revenue (1Y)19,76%
Earnings (1Y)136,65%
FCF Growth (3Y)182,33%
Qualité
Return on Equity
3,06%
ROIC0,33%
Net Margin3,10%
Op. Margin0,72%
Sécurité
Debt / Equity
0,57
Current Ratio2,21
Interest Coverage0,26
Valorisation
P/E Ratio
171,25
P/B Ratio5,18
EV/EBITDA803,78
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,76% | Revenue Growth (3Y) | 12,70% |
| Earnings Growth (1Y) | 136,65% | Earnings Growth (3Y) | 267,26% |
| Revenue Growth (5Y) | 13,92% | Earnings Growth (5Y) | 5,12% |
| Profitability | |||
| Revenue (TTM) | 269,26M | Net Income (TTM) | 8,35M |
| ROE | 3,06% | ROA | 1,49% |
| Gross Margin | 75,89% | Operating Margin | 0,72% |
| Net Margin | 3,10% | Free Cash Flow (TTM) | 9,34M |
| ROIC | 0,33% | FCF Growth (3Y) | 182,33% |
| Safety | |||
| Debt / Equity | 0,57 | Current Ratio | 2,21 |
| Interest Coverage | 0,26 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 171,25 | P/B Ratio | 5,18 |
| P/S Ratio | 5,31 | PEG Ratio | 0,75 |
| EV/EBITDA | 803,78 | Dividend Yield | 0,00% |
| Market Cap | 1,43B | Enterprise Value | 1,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 269,26M | 224,83M | 212,01M | 182,82M | 159,88M |
| Net Income | 8,35M | 3,53M | 619 000,0 | -5,78M | 6,84M |
| EPS (Diluted) | 0,67 | 0,26 | 0,05 | -0,49 | 0,58 |
| Gross Profit | 204,33M | 178,68M | 167,57M | 135,39M | 121,57M |
| Operating Income | 1,93M | 7,87M | 9,10M | -1,87M | 11,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 559,92M | 459,96M | 349,53M | 327,89M | 298,18M |
| Total Liabilities | 284,05M | 190,32M | 94,58M | 90,11M | 74,18M |
| Shareholders' Equity | 275,87M | 269,65M | 254,96M | 237,78M | 224,00M |
| Total Debt | 157,72M | 120,29M | 27,39M | 52,04M | 24,07M |
| Cash & Equivalents | 32,97M | 138,69M | 25,20M | 20,60M | 82,64M |
| Current Assets | 195,28M | 265,95M | 141,42M | 137,88M | 175,48M |
| Current Liabilities | 88,17M | 51,02M | 45,96M | 39,53M | 34,71M |